Financials data is unavailable for this security.
Cash flow in JPYView more
In 2023, cash reserves at Kringle Pharma Inc fell by 740.81m. Cash Flow from Financing totalled 69.16m or 99.88% of revenues. In addition the company used 689.10m for operations while cash used for investing totalled 120.88m.
Cash flow per share | -131.24 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 344.17 |
---|---|
Tangible book value per share | 344.17 |
More ▼
Balance sheet in JPYView more
Current ratio | 35.16 |
---|---|
Quick ratio | 30.96 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼